DOI: https://dx.doi.org/10.18203/2349-2902.isj20220357
Published: 2022-01-29

Role of Ayurveda in the management of Vatashthila W. S. R. to benign prostatic hyperplasia: a review study

Shriniwas Gujjarwar, Shalu .

Abstract


In Ayurvedic texts vatashthila [i.e.; benign prostatic hyperplasia (BPH)] is a one of major urinary disorder described in mutraghata (i.e.; decreased urine flow due to obstructionin urinary passage). It is a very major common problem in geriatric age group in males (usually in 60-70 years of age). Histo-pathologically the prevalence of BPH is age dependent, initiate usually after 40 years of age. More than 50% of men in their 60s and upto 90% of men in their 70s and 80s have some symptoms of BPH. In contemporary science conservative and surgical treatment are given to the patients suffering with BPH. The symptoms of vatashthila have been described in mutraghata resembles to the benign prostatic hyperplasia in modern science. The aim of the study is to focus on various studies done on vatashthila (i.e.; BPH) between 2016-2021. The various studies have been done on efficacy of Kanchnar guggulu, Trikantakadi guggulu, Veertarnadi gana kshaya, Varun bark decoction (Kwath), Ushiradi taila as Uttarbasti and Dhanyak gokshur ghrita yavkshar as Uttarbasti in the management of Vatashthila (BPH). These studies may be very beneficial to improve the tonicity of urinary bladder and to reduce the size of the prostate.


Keywords


Vatashthilla, Benign prostatic hyperplasia, Ayurvedic drugs, Uttarbasti

Full Text:

PDF

References


Sushrut S, Ambikadatta S. Chaukhamba Sanskrit Sanshthan. Varanasi: Chaukhambha Sanskrita Sireej; 2011: 538-549.

Das S. A concise Text Book of surgery. 3rd ed. Kolkata: Dr. Somen Das Publications; 2016: 1269-1293.

Chapple C. Medical treatment for benign prostatic hyperplasia. BMJ. 1992; 304:1198-9.

Parsons JK. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol. 2007;178(2):395-401.

Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474-9.

National Institute of Diabetes and Digestive and Kidney Diseases. Prostate enlargement: benign prostatic hyperplasia. USA: NIH Publication; 2006: 7-3012. Available at: http://www.niddk.nih.gov. Last accessed on 02 November 2021.

Fenter TC, Naslund MJ, Shah MB, Eaddy MT, Black L. The cost of treating the 10 most prevalent diseases in men 50 years of age or older. Am J Manag Care. 2006;12(4):90-8.

McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793-803.

Tseng CH. Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan. BMC Cancer. 2013;13:7.

Alcaraz A, Hammerer P, Tubaro A, Schröder FH, Castro R. Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review. Eur Urol. 2009;55(4):864-73.

Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10-29.

Das S. A concise Text Book of surgery. 3rd ed. Kolkata: Dr. Somen Das Publications; 2016: 1274.

Samhita S, Sharma A. Sushrut vimarshini hindi commentary. 1st ed. Varanasi: Chaukhamba Surbharati Prakashan; 2001: 454.

Ørsted DD, Bojesen SE, Nielsen SF, Nordestgaard BG. Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men. Eur Urol. 2011;60(4):691-8.

Ratnakar Y. Vidyotini Hindi commentary. Laxmipati Shastri Mutraghat Chikitsa, Chaukhambha Sanskrita Sireej Office: Varanasi; 1973.

Samhita S, Sharma A. Sushrut vimarshini hindi commentary, Volume II. 1st ed. Varanasi: Chaukhamba Surbharati Prakashan; 2001: 237.

Sharma AR. Cuttartantra. Sushruta Samhita. Varanasi: Chaukshmba Surbharati Prakshan; 2008: 29-72.

Shastri L. Yogratnakar with Vidyotini Hindi commentary. IJTRA. 2016;443-7.

Rajeev K, Rakesh R, Sharma PK, Gupta AK. A clinical study to evaluate the efficacy of trikantakadi guggulu in the management of vatashthila W.S.R. to benign prostatic hyperplasia (BPH). Int J Tech Res Appl. 2016;4(3):43-7.

Meena R, Sharma PK, Verma V, Verma S, Sourmi, Sharma SK. A comparative clinical study of veertarvadi gana kashaya and basti therapy in the management of vatashtheela with special reference to benign prostatic hyperplasia. World J Pharma Res. 2018;7(12):516-32.

Jyotik OS, Borse NV. A case study of nirgundi (vitex negundo linn.) taila in the management of dushta vrana. Int J Res Ayu Med Sci. 2020;3(3):154-6.

Danish J. To evaluate the effect of "kanchnara guggulu and vir-tarvadi gana kashaya" in management of b.p.h (benign prostate hyperplasia). Unique J Ayurvedic Herbal Med Clinical Study. 2015;10.

Gupta A, Goyal C, Singh A. A comparative clinical study of Khanda Shunthi and Prasarni Avaleha in the Management of Ama Vata w.s.r. to Rheumatoid Arthritis. Int J Ayurvedic Med. 2010:12(2):954-60.

Samhita S, Sharma A. Sushrut vimarshini hindi commentary. Chaukhamba Surbharati Prakashan, Varanasi 1st ed. Varanasi: Udavarta Pratisedha Adhyay; 2001: 454.

Samhita S, Sharma A. Sushrut vimarshini hindi commentary. Chaukhamba Surbharati Prakashan, Varanasi 1st ed. Varanasi: Udavarta Pratisedha Adhyay; 2001: 454.

Samhita S, Sharma A. Sushrut vimarshini hindi commentary. Chaukhamba Surbharati Prakashan, Varanasi 1st ed. Varanasi: Udavarta Pratisedha Adhyay; 2001: 454.

Sushruta S. Ambikadutt S. Chaukhamba Sanskrit sansthan. Varanasi: Chaukhamba Sanskrit Sireej; 2011:547.

Samhita S. Ambikadatta S. Chaukamba Sanskrit Sansthan. Varanasi: Chaukhamba Sanskrit Sireej; 2011: 544-549.

Samhita S, Sharma A. Sushrut vimarshini hindi commentary. Chaukhamba Surbharati Prakashan, Varanasi 1st ed. Varanasi: Udavarta Pratisedha Adhyay; 2001: 454.

Das S. A concise Text Book of surgery. 8th ed. Kolkata: Dr. Somen Das Publications; 2014: 1277-8.

Ewing LL.The development of human benign prostatic hyperplasia with age. J Urol.,1984;132(3):474-9.

National Institute of Diabetes and Digestive and Kidney Diseases. Prostate enlargement: benign prostatic hyperplasia. NIH Publication., June 2006; 07-3012.

Fenter TC, Naslund MJ, Shah MB, Eaddy MT, Black L. The cost of treating the 10 most prevalent diseases in men 50 years of age or older. Am J Manag Care., 2006; 12(4): S90-S98.

Das, Somen; ‘A concise textbook of surgery’, Third edition; Kolkatta; Dr.S.Das; 2016.PP-1274.

Sushrut Samhita, Dr. Anantram Sharma, Sushrut vimarshini hindi commentary, Chaukhamba Surbharati Prakashan, Varanasi 1st edition, 2001 Vol.III, Udavarta Pratisedha Adhyaya Su.UT.55/9-10,page no-454.

Chaukhamba sanskrit Series office, Varanasi; 1973, Ratnakar, vidyotini Hindi commentary, Laxmipati shastri Mutraghata chikitsa.

Sushruta Samhita, Dr. Anantram Sharma, Sushrut vimarshini hindi commentary, Chaukhamba Surbharati Prakashan, Varanasi 1st edition, 2001, Vol.II, ashmari chikitsaadhyaya, Su.Chi 7/27, Page No. 237.1.

Sharma AR. Sushruta Samhita Vol-3 Cuttartantra chp. 58). Varanas; Chaukshmba Surbharati Prakshan ; 2008. P. 29-72. ,

International Journal of Technical Research and Applications e-ISSN: 2320-8163, Volume 4, Issue 3 (May-June, 2016), PP. 43-47.

World Journal of Pharmaceutical Research, ISSN 2277– 7105, SJIF Impact Factor 8.074 Volume 7, Issue 12, 516-532..

(INTERNATIONAL JOURNAL OF RESEARCH IN AYURVEDA AND MEDICAL SCIENCES, ISSN: 2582-2748, Vol 3, Issue 3. (Jul - Sept 2020),pp154-156.

.Unique Journal of Ayurvedic and Herbal Medicines, ISSN 2347-2375, 03 (01), Jan-Feb 2015, Page 67-74.

International Journal of Ayurvedic Medicine, ISSN No: 0976-5921,Vol 12 (2), 427-430.